about
Analysis of the protein domain and domain architecture content in fungi and its application in the search of new antifungal targetsData mining validation of fluconazole breakpoints established by the European Committee on Antimicrobial Susceptibility TestingEvaluation by data mining techniques of fluconazole breakpoints established by the Clinical and Laboratory Standards Institute (CLSI) and comparison with those of the European Committee on Antimicrobial Susceptibility Testing (EUCAST)Comparison of the Vitek 2 antifungal susceptibility system with the clinical and laboratory standards institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the SensitiAnalysis of strain relatedness using high resolution melting in a case of recurrent candiduriaHigh incidence of human bocavirus infection in children in Spain.Frequency of voriconazole resistance in vitro among Spanish clinical isolates of Candida spp. According to breakpoints established by the Antifungal Subcommittee of the European Committee on Antimicrobial Susceptibility Testing.Sequence Analysis of In Vivo-Expressed HIV-1 Spliced RNAs Reveals the Usage of New and Unusual Splice Sites by Viruses of Different Subtypes.Identification of Novel Short C-Terminal Transcripts of Human SERPINA1 GeneCandida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications.Clinical relevance of resistance to antifungals.In vitro activity of antifungals against Zygomycetes.Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis virulence in the non-conventional host Galleria mellonella.Structural phosphoprotein M2-1 of the human respiratory syncytial virus is an RNA binding protein.Apoptosis, Toll-like, RIG-I-like and NOD-like Receptors Are Pathways Jointly Induced by Diverse Respiratory Bacterial and Viral Pathogens.Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.Human respiratory syncytial virus matrix protein is an RNA-binding protein: binding properties, location and identity of the RNA contact residues.First Draft Genome Sequence of a Clinical Strain of Nocardia cerradoensis.Ribosomic DNA intergenic spacer 1 region is useful when identifying Candida parapsilosis spp. complex based on high-resolution melting analysis.High-Quality Draft Genome Sequence of Babesia divergens, the Etiological Agent of Cattle and Human Babesiosis.In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus.Voriconazole serum levels measured by high-performance liquid chromatography: a monocentric study in treated patients.Phosphorylation of the human respiratory syncytial virus N protein provokes a decrease in viral RNA synthesis.First Insight into the Genome Sequences of Two Linezolid-Resistant Nocardia farcinica Strains Isolated from Patients with Cystic Fibrosis.Three-dimensional models of 14α-sterol demethylase (Cyp51A) from Aspergillus lentulus and Aspergillus fumigatus: an insight into differences in voriconazole interaction.Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis.Antifungal susceptibility profile of clinical Alternaria spp. identified by molecular methodsMolecular identification and susceptibility profile in vitro of the emerging pathogen Candida kefyrPhylodynamics of SARS-CoV-2 transmission in Spain
P50
Q28540822-2204321A-E415-4B9F-8A54-2A9A97016E6DQ33443651-23E63823-C2F5-4A3D-B6BE-505B12520AB5Q33528384-642404A9-141B-452E-8C1B-43D33976045EQ33827176-6C542EFB-8541-4CBE-889E-360FF0312670Q34559832-CF827EC3-6361-44FC-9EF1-3395F2596BFAQ34695355-7413D524-C044-4F17-9DCA-FE7057D09686Q34737476-11D17780-FAF6-4ABE-BA43-C267D016F3AFQ36063873-AA350C4B-5A02-46A9-806A-61EF3F890F08Q36255691-C736E848-5661-4F8F-8FBC-994E9605CFF3Q37263791-B0A62880-1F76-4470-AAE4-553817EC3BC8Q37327076-A9BEAE4D-8882-4CBE-931F-6AFE4CC559E1Q37597559-F56960C3-0C06-46FD-976C-E29C1BD32A8AQ38297389-610E7C5B-9417-4420-A619-1910EE197418Q39539425-31B0FD93-8F2E-483F-83DC-0A58B5F17F0DQ40290315-38578943-056E-4358-8A5E-9D8FBCD147F4Q40538476-56F6415F-1FFC-4747-B544-7B2C489F9FC7Q40583491-F87A80EB-CB92-4A00-B91F-017138191DC6Q41786713-86AC2F20-0125-466E-811D-B57F9572273CQ42214488-9DA808A3-8D6D-4AC2-B0F6-3E563F412E8BQ43025701-FF6444EC-3DA6-4620-9222-2656E4D0F478Q43505835-04440509-4139-475F-B96A-0F997A6C45F9Q44294733-105E3214-B6D3-4B2A-A232-F8010913B89AQ45362227-8C48C964-8753-4899-A164-8AFA8C8514A8Q47119860-51709197-2CB9-4298-AF5D-FD654D60D605Q48056256-6C37615B-BEB1-4C02-9372-5F8E17E4D2E7Q51047839-9B7384D4-5CD3-4E7A-B33B-FE9795F4E053Q57651704-6288B3C7-B85D-4CA8-B376-1BB1D06851F5Q57651721-5246BBDA-C8FA-4A6B-9FB3-A7832A1C2D5BQ95627476-56052C90-9272-4F39-AEBE-E5F8FD9E0B6B
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Isabel Cuesta
@ast
Isabel Cuesta
@en
Isabel Cuesta
@es
Isabel Cuesta
@nl
Isabel Cuesta
@sl
type
label
Isabel Cuesta
@ast
Isabel Cuesta
@en
Isabel Cuesta
@es
Isabel Cuesta
@nl
Isabel Cuesta
@sl
prefLabel
Isabel Cuesta
@ast
Isabel Cuesta
@en
Isabel Cuesta
@es
Isabel Cuesta
@nl
Isabel Cuesta
@sl
P1053
C-1628-2018
P106
P21
P31
P3829
P496
0000-0002-7911-9041